EUVIMEDEUVIMED entdecken
Crossref

In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment

Miah Roney, Abdul Rashid Issahaku, A K M Moyeenul Huq, Suhaila Sapari, Fazira Ilyana Abdul Razak, Anke Wilhelm, Normaiza Binti Zamri, Sabrina Sharmin, Md Rabiul Islam, Mohd Fadhlizil Fasihi Mohd Aluwi

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01419-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Miah Roney und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Lebuhraya Persiaran Tun Khalil Yaakob, Kuantan, Pahang,…. Hauptthemen laut MEDLINE: alpha-Amylases, Molecular Docking Simulation, Benzofurans, Molecular Dynamics Simulation. Die Arbeit nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) a metabolic disorder characterized by high blood sugar levels causing damage to various organs over time. Current anti-diabetic drugs have limitations and side effects, prompting a search for new inhibitors targeting the α-amylase enzyme. This study aims to discover such inhibitors from thirty isoxazole derivatives of usnic acid using in silico approaches. The potential inhibitory effects of compounds were investigated using ADMET, molecular docking, molecular dynamic simulation, principal component analysis and density functional theory studies. ADMET analysis exhibited a wide range of physicochemical, pharmacokinetic, and drug-like qualities with no significant side effects which were then investigated using molecular docking experiment to determine the lead compound with the best binding affinity for the α-amylase enzyme. All compounds showed good binding affinity against α-amylase enzyme (-7.9 to -9.2 kcal/mol) where compound-13 showed the best binding affinity of -9.2 kcal/mol forming hydrogen bonds with Leu162, Tyr62, Glu233 and Asp300 amino acids. Furthermore, the binding posture and the stability of the compound-13-α-amylase enzyme complex was confirmed by molecular dynamic simulation experiment. Moreover, compound-13 showed binding energy value of -27.92 ± 5.61 kcal/mol, which indicated it could be an α-amylase inhibitor. Additionally, the reactivity of compound-13 was further confirmed by density functional theory analysis. The above findings suggest compound-13 to be a potential α-amylase inhibitor in DM. And setting the stage for further in vitro and in vivo experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-AmylasesMolecular Docking SimulationBenzofuransMolecular Dynamics SimulationHydrogen BondingIsoxazolesDiabetes MellitusBinding SitesHypoglycemic AgentsHumansProtein BindingEnzyme InhibitorsCatalytic DomainPrincipal Component AnalysisComputer SimulationThermodynamics

Stichwörter der Autor:innen

Anti-diabeticDFTMD Simulationdockingα-amylase

Substanzen

alpha-AmylasesBenzofuransusnic acidIsoxazolesHypoglycemic AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Lebuhraya Persiaran Tun Khalil Yaakob, Kuantan, Pahang, Malaysia.
  • Centre for Bio-aromatic Research, Universiti Malaysia Pahang Al-Sultan Abdullah, Lebuhraya Persiaran Tun Khalil Yaakob, Kuantan, Pahang, Malaysia.
  • Department of Chemistry, University of the Free State, 205 Nelson Mandela Avenue, Bloemfontein, 9301, South Africa.
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz-50300, Kuala Lumpur, Malaysia.
  • Department of Chemistry, Faculty of Science, University Technology of Malaysia, Skudai, 81310, Johor Bahru, Johor, Malaysia.
  • School of Pharmacy, BRAC University, 66 Mohakhali, Dhaka, 1212, Bangladesh.

Zitieren

APA

Roney, M., Issahaku, A. R., Huq, A. K. M. M., Sapari, S., Abdul Razak, F. I., Wilhelm, A., Zamri, N. B., Sharmin, S., Islam, M. R., & Mohd Aluwi, M. F. F. (2024). In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01419-1

Vancouver

Roney M, Issahaku AR, Huq AKMM, Sapari S, Abdul Razak FI, Wilhelm A, et al. In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01419-1

BibTeX
@article{Roney2024,
  author = {Roney, Miah and Issahaku, Abdul Rashid and Huq, A K M Moyeenul and Sapari, Suhaila and Abdul Razak, Fazira Ilyana and Wilhelm, Anke and Zamri, Normaiza Binti and Sharmin, Sabrina and Islam, Md Rabiul and Mohd Aluwi, Mohd Fadhlizil Fasihi},
  title = {In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01419-1}
}
Kostenlos starten →